{"id":5532,"date":"2021-04-28T13:21:28","date_gmt":"2021-04-28T13:21:28","guid":{"rendered":"https:\/\/www.skincancer.org\/?p=5532"},"modified":"2021-06-07T19:49:06","modified_gmt":"2021-06-07T19:49:06","slug":"when-a-common-skin-cancer-advances","status":"publish","type":"post","link":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/","title":{"rendered":"When a Common Skin Cancer Advances","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"<h4>Among the millions of people diagnosed with basal cell carcinoma (BCC) each year, most are easily treated, but some are not so lucky. Our experts explain how BCC can become advanced and, in rare cases, even life-threatening. Today there are more options for these patients, and this guide provides knowledge, navigation and support.<\/h4>\n<p>One of the toughest things a doctor ever has to do is deliver a cancer diagnosis \u2014 but dermatologists do it every day. Skin cancer is common; in fact, basal cell carcinoma (BCC) is the world\u2019s most common cancer, so dermatologists see a lot of it. While it is difficult to pinpoint the exact number of BCC cases in the U.S., The Skin Cancer Foundation estimates it as <a href=\"https:\/\/www.skincancer.org\/blog\/our-new-approach-to-a-challenging-skin-cancer-statistic\/\">3.6 million<\/a> a year. That\u2019s nearly 10,000 diagnoses a day.<\/p>\n<h3><strong>Some BCC Basics<\/strong><\/h3>\n<ul>\n<li>BCCs are uncontrolled growths that arise from basal cells in the outermost layer of the skin. Most BCCs are caused by exposure to ultraviolet (UV) radiation from the sun. UV from indoor tanning can also increase risk for BCC.<\/li>\n<li>Over time, UV radiation damages DNA in the skin. The body repairs some of the damage, but what remains unrepaired can trigger mutations that lead to skin cancer.<\/li>\n<li>Not all BCCs look alike. In fact, they might look like a pimple, a sore that doesn\u2019t heal, a shiny bump, a scar-like area, a pink or reddish patch or something else. In patients with darker skin, about half of BCCs are pigmented (meaning brown in color). Some people develop multiple BCCs over a lifetime.<\/li>\n<li><strong>The good news:<\/strong> Because skin cancer is a cancer you can see, these tumors tend to be detected early, when they are easiest to treat and have the best chance of a cure. The Skin Cancer Foundation\u2019s Big See campaign keeps it simple: Look for anything <strong>new, changing<\/strong> or <strong>unusual<\/strong> on your skin and let your dermatologist know. With early detection and prompt treatment, almost all BCCs can be successfully cured without complications.<\/li>\n<li><strong>The not-so-good news:<\/strong> There are some exceptions. \u201cIt\u2019s essential for people to understand that in its advanced stages, BCC can be disfiguring and even deadly if left untreated, just like any other cancer,\u201d says John Strasswimmer, MD, PhD, a board-certified dermatologist based in Palm Beach County, Florida, who focuses on Mohs surgery and cutaneous oncology. \u201cWe\u2019re just lucky that we have become good at diagnosing and treating it most of the time.\u201d<\/li>\n<\/ul>\n<h3><strong>Below the Surface<\/strong><\/h3>\n<p>BCCs are notorious for often looking like \u201cno big deal\u201d on the surface while growing \u201croots\u201d that can burrow deep into the skin and cause damage. Like rogue tree roots that burrow into the ground and disrupt underground plumbing, cable and utility services, BCCs can invade deep into the skin and even damage nerves, muscle and bone.<\/p>\n<p>\u201cWhat we see with BCC on the outside may not always be what is present on the inside,\u201d Dr. Strasswimmer explains. There are several reasons for this. Sometimes it is just the way the cancer grows. Other times it may be due to a previous treatment that didn\u2019t remove the entire tumor. While researchers are looking into new ways of imaging that may eventually help dermatologists see what is under the skin, for now there is no crystal ball.<\/p>\n<p>Luckily, though, there is Mohs surgery. This gold standard technique allows a specially trained surgeon to remove a layer of tissue at a time, examine the tissue under a microscope in an adjacent lab, identify exactly if and where any remaining cancerous cells are located and repeat the process until no microscopic cancer cells remain. The surgeon examines nearly 100 percent of the tumor margins, spares healthy tissue and leaves the smallest scar possible.<\/p>\n<div id=\"attachment_5540\" style=\"width: 710px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-5540\" class=\"wp-image-5540 size-full\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/Surgery-strasswimmer.jpg\" alt=\"Dr Strasswimmer performing Mohs surgery\" width=\"700\" height=\"467\" srcset=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/Surgery-strasswimmer.jpg 700w, https:\/\/www.skincancer.org\/wp-content\/uploads\/Surgery-strasswimmer-600x400.jpg 600w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><p id=\"caption-attachment-5540\" class=\"wp-caption-text\"><strong>Focus on Mohs Surgery.<\/strong> Dr. Strasswimmer started his practice in Southeast Florida in 2005 to fill a need for specialized care for patients with advanced skin cancer. <em>Photo: John Strasswimmer, MD, PhD<\/em><\/p><\/div>\n<p>Dr. Strasswimmer recalls a patient with a very small BCC on the side of her nose that looked like a small red patch or a pimple. \u201cWhen I did my first Mohs surgery layer removal, I could see that the tumor was going quite deep. By the time I got the tumor out, it was down to the bone. We had to remove the outer layer of the bone and then do some reconstruction.\u201d<\/p>\n<p>He later learned that previously the patient\u2019s BCC had been burned off superficially by an electrolysis device for hair removal. \u201cThat removed the visible part on the surface but did not remove the whole tumor and thus allowed cancerous cells to proliferate underneath and cause a tremendous amount of devastation,\u201d Dr. Strasswimmer says. Some people have used DIY devices and home remedies they read about to remove a lesion or mole from their skin. This is a dangerous practice that can make early detection and treatment of skin cancers such as BCCs much more difficult.<\/p>\n<h3><strong>What Is Advanced BCC? <\/strong><\/h3>\n<p>Remember, the majority of BCCs are caught early. Some very early lesions may be treated with minimally invasive options such as topical treatments, curettage and electrodesiccation, cryotherapy or laser surgery. Others may be treated with excisional surgery, Mohs surgery or radiation. (See the SCF <a href=\"https:\/\/www.skincancer.org\/treatment-resources\/treatment-glossary\/\">Treatment Glossary<\/a> for more information.)<\/p>\n<p>However, a small proportion of tumors can become advanced and penetrate deep into the skin and surrounding tissues (locally advanced) or spread to other parts of the body (metastatic). Treatment for advanced BCC may include surgery, radiation or systemic medications, which treat the cancer from inside the body.<\/p>\n<p>How do BCCs become advanced? In many cases, patients with advanced BCC have had previous treatment or multiple treatments, but the cancer has recurred or spread, says Lara A. Dunn, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.<\/p>\n<div id=\"attachment_5537\" style=\"width: 350px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-5537\" class=\"wp-image-5537\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/john-strasswimmer-md-headshot-539x600.jpg\" alt=\"John Strasswimmer MD, PhD\" width=\"340\" height=\"379\" srcset=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/john-strasswimmer-md-headshot-539x600.jpg 539w, https:\/\/www.skincancer.org\/wp-content\/uploads\/john-strasswimmer-md-headshot.jpg 600w\" sizes=\"auto, (max-width: 340px) 100vw, 340px\" \/><p id=\"caption-attachment-5537\" class=\"wp-caption-text\"><strong>Early Detection Is the Key!<\/strong> Postponing a dermatologist visit, says Dr. Strasswimmer, may allow small BCC tumors to grow and become advanced. <em>Photo: John Strasswimmer, MD, PhD<\/em><\/p><\/div>\n<p>In other cases, it is simply due to \u201cbenign neglect,\u201d Dr. Strasswimmer says. There are lots of reasons for this, including fear of what a lesion might be, fear of what the treatment might entail or worries about medical costs or lack of insurance. He has seen many patients in his practice with advanced BCC who were diagnosed years earlier and left untreated.<\/p>\n<p>\u201cIn some cases, BCCs may not be that uncomfortable,\u201d he adds. \u201cPatients may keep a lesion hidden from loved ones and procrastinate on seeing a doctor about it until it grows very large. People underestimate how cost-effective in-office surgery can be, which likely could have cured the BCC if treated early. Many patients have postponed seeing their dermatologist during this long pandemic, and that\u2019s understandable. But it also can be costly \u2014 in more ways than one.\u201d<\/p>\n<p>There are two categories of advanced BCC: locally advanced and metastatic.<\/p>\n<p><strong>Locally Advanced BCC:<\/strong> The definition of locally advanced BCC generally includes several types of presentations: large, deep, aggressive tumors; those that have recurred after treatment; and cases where surgery or radiation would not be effective or appropriate.<\/p>\n<p>\u201cAfter a previous treatment, the BCC may have recurred in the area where it started, or in the surrounding area, and caused extensive damage to surrounding tissue, muscle, bone or nerves,\u201d says Dr. Dunn. \u201cOr it could have traveled through the regional lymphatic system into the lymph node nearest where the tumor originated.\u201d<\/p>\n<p>Some patients with locally advanced BCC have already been treated with <em>multiple<\/em> surgeries and radiation, she explains, which can make it almost impossible to get clear results with another surgery. Or, the tissue may have already been exposed to the maximum amount of radiation it can receive. Dr. Strasswimmer stresses the importance of seeing a board-certified radiation oncologist.<\/p>\n<p>Dr. Dunn says there are also cases in which these tumors are neglected and have become so large that an initial surgery is not an option or would be so extensive that it would greatly affect function, such as removal of the eye, she explains. \u201cIn those situations, we might be able to try radiation.\u201d<\/p>\n<p><strong>Metastatic BCC<\/strong>: Far less common than locally advanced, metastatic BCC is when the cancer has \u201cbroken loose,\u201d as Dr. Strasswimmer describes it, and spreads to a distant lymph node or to another organ in the body, such as the lungs, or sometimes to another area in the skin. About 70 percent of total metastatic cases spread through the lymphatic system, but they can also spread through the bloodstream or under the skin.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat( auto-fit, minmax(380px, 1fr)); border: 1px solid black;\">\n<div style=\"padding: 1em;\">\n<h4><strong>How Many People Develop Advanced BCC?<\/strong><\/h4>\n<p>Because nonmelanoma skin cancer is not tracked by cancer registries in the U.S., it is difficult to pinpoint the number of BCC\u00a0 cases, let alone advanced BCCs. Studies have suggested that a range of 1 to 10 percent of total cases of BCC become advanced. The Skin Cancer Foundation uses the conservative estimate of 1 percent. Of those, 95 percent are estimated as locally advanced and about 5 percent are metastatic.<\/p>\n<\/div>\n<div><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-5546 aligncenter\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/advanced-bcc-graphic-2-490x600.jpg\" alt=\"\" width=\"340\" height=\"417\" srcset=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/advanced-bcc-graphic-2-490x600.jpg 490w, https:\/\/www.skincancer.org\/wp-content\/uploads\/advanced-bcc-graphic-2.jpg 683w\" sizes=\"auto, (max-width: 340px) 100vw, 340px\" \/><\/div>\n<\/div>\n<h3><strong><br \/>\nSystemic Treatments for Advanced BCC<\/strong><\/h3>\n<p>Seeing patients with advanced BCC earlier in his career \u201cwas a heartbreaking time,\u201d Dr. Strasswimmer remembers, \u201cbecause we had patients then who could not be treated. Surgery and radiation were no longer options. All we could do was to provide comfort and keep their symptoms as controlled as possible.\u201d<\/p>\n<p>Today there are newer options for these patients. For some advanced cases, patients may receive a type of medicine taken orally called hedgehog inhibitors, or HHIs. This medication works by blocking abnormal signals that promote cancerous growth. \u201cHowever, if a patient develops a tumor that is resistant to these medications or has not tolerated them due to side effects, there hasn\u2019t always been a standard backup option for them,\u201d says Dr. Strasswimmer.<\/p>\n<p>Immunotherapy is another systemic treatment option that has been helping patients with many types of advanced cancers in recent years. Immunotherapy works by using the body\u2019s own immune system to help attack cancer cells. Intravenously infused immunotherapy medications called checkpoint inhibitors work by blocking a protein receptor called PD-1 (programmed death-1), which, under normal circumstances, helps keep the immune system in check. These drugs release T cells to fight the cancer.<\/p>\n<p>Research is rapidly progressing, and keeping up with the latest advancements can make all the difference for patients. Dr. Dunn says she is hopeful that emerging therapies will provide additional options for her advanced BCC patients.<\/p>\n<p>Dr. Strasswimmer is also encouraged by recent developments in the treatment of advanced BCC and the impact it could have on his patients.<\/p>\n<div class=\"whos-on-your-team-sidebar\" style=\"border: 1px solid black; padding: 1em;\">\n<h4><strong>Trouble Spots for Detecting BCCs<\/strong><\/h4>\n<p>While BCCs are often slow-growing tumors, some can grow rapidly. BCCs in certain locations, Dr. Dunn emphasizes, can be harder to diagnose early.<\/p>\n<p><strong>Eyes:<\/strong> When a BCC grows on the eyelids or along the eyelash lines, they are hard to see and often, unfortunately, are diagnosed late, she says.<\/p>\n<p><strong>Ears:<\/strong> Because of the nature of people wearing eyeglasses or sunglasses on the ears, a BCC under there may not be diagnosed until it has spread quite extensively. When they grow into the skin and encounter the cartilage, \u201cthey grow sideways between the cartilage of the ear and the skin, kind of like a fried egg under the surface,\u201d Dr. Dunn describes.<\/p>\n<p><strong>Tip of the nose:<\/strong> People love baseball caps, but they don\u2019t protect the tip of the nose from the sun. Most people don\u2019t apply enough sunscreen to the area, and don\u2019t reapply often enough, either. Dr. Dunn says, \u201cSome of the most heartbreaking patients I have seen are young, otherwise very healthy people, who have a BCC on the tip of the nose that becomes advanced. It can be a challenge to remove the tumor and do a careful reconstruction to maintain their cosmetic appearance, but also for the nostrils to stay open properly and maintain their proper function.\u201d<\/p>\n<\/div>\n<div class=\"whos-on-your-team-sidebar\">\n<h4><strong>Questions to ask your doctor if you have been diagnosed with advanced BCC:<\/strong><\/h4>\n<ul>\n<li>What other types of specialists should I see, whether at a cancer center or referred by my dermatologist?<\/li>\n<li>What treatments are possible for my advanced BCC?<\/li>\n<li>Is surgery still an option and, if so, how might it affect the function of the area, if the surgery is on my eyelid, lip or hand, for example?<\/li>\n<li>Could radiation help me? If so, how many treatments would be necessary, and what side effects should I expect?<\/li>\n<li>Is a systemic medicine an option for me?<\/li>\n<li>How does systemic medication work, how is it administered and what should I expect?<\/li>\n<li>What are the side effects I might experience from systemic therapy, and who would I tell about them?<\/li>\n<li>Is there a clinical trial I might be eligible for?<\/li>\n<\/ul>\n<\/div>\n<div class=\"whos-on-your-team-sidebar\">\n<h4><strong>Who\u2019s on Your Team?<\/strong><\/h4>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-5548 size-thumbnail\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-line-drawing-1214776673-340x240.jpg\" alt=\"line drawing of doctor team\" width=\"340\" height=\"240\" \/>Patients with any advanced cancer can benefit from <a href=\"https:\/\/www.skincancer.org\/blog\/building-your-skin-cancer-team\/\">multidisciplinary care<\/a>, which includes bringing in the appropriate specialists based on what is needed and making sure everyone on the team collaborates and communicates. While a cancer center or academic center may have multidisciplinary care built in, doctors in private practice also know how to rally a team.<\/p>\n<p>For example, Dr. Strasswimmer says that there are no flagship cancer institutions where he lives in South Florida, and where he\u2019s been practicing since 2005. He learned to manage very complex cases and crafted his practice to encompass Mohs surgery and multidisciplinary approaches with medical oncologists to prescribe systemic therapies.<\/p>\n<p>He serves as the center of the team and may call on specialists such as a head and neck surgeon, or an oculoplastic surgeon for a complicated advanced BCC on the eyelid or near the tear duct, for example. He and his colleagues have the ability to meet in person to review cutaneous oncology cases (a \u201ctumor board\u201d) and also to examine patients together as a group (a multimodality clinic). In the era of COVID-19, this has been modified to incorporate digital collaboration. \u201cWe\u2019ve developed good relationships with our multidisciplinary colleagues,\u201d he says. \u201cWe have a true collegial back-and-forth.\u201d<\/p>\n<p>At Memorial Sloan Kettering, one of the top cancer centers in the world, Dr. Dunn specializes in advanced nonmelanoma skin cancers (including BCC, the most common type, and cutaneous squamous cell carcinoma, or CSCC, the second most common type of skin cancer). As a medical oncologist, her patients may be referred to her by a dermatologist, or by a Mohs surgeon or surgical oncologist within the center. She also works closely with the radiation oncologists in the center and other specialists as needed.<\/p>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-5538 alignnone\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/scf-regeneron-logos.jpg\" alt=\"\" width=\"600\" height=\"140\" \/><br \/>\n<em>Regeneron and Sanofi financially supported and collaborated in the development of this article with The Skin Cancer Foundation.<\/em><\/p>\n<p>ONC.21.020031\u00a0 04\/2021<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-5474 alignleft\" src=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/featured-in-journal-2021.jpg\" alt=\"Featured in The 2021 Skin Cancer Foundation Journal\" width=\"450\" height=\"79\" \/><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"<p>Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":1,"featured_media":5535,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10,2880],"tags":[5512,14,3260,3258,5505],"class_list":["post-5532","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-skin-cancer-information","category-the-skin-cancer-foundation-journal","tag-advanced-basal-cell-carcinoma","tag-basal-cell-carcinoma","tag-bcc","tag-mohs-surgery","tag-non-melanoma-skin-cancers"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3 (Yoast SEO v25.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>When a Common Skin Cancer Advances - The Skin Cancer Foundation<\/title>\n<meta name=\"description\" content=\"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"When a Common Skin Cancer Advances\" \/>\n<meta property=\"og:description\" content=\"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\" \/>\n<meta property=\"og:site_name\" content=\"The Skin Cancer Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/skincancerfoundation\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T13:21:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-07T19:49:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Skin Cancer Foundation\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@skincancerorg\" \/>\n<meta name=\"twitter:site\" content=\"@skincancerorg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Skin Cancer Foundation\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\"},\"author\":{\"name\":\"Skin Cancer Foundation\",\"@id\":\"https:\/\/www.skincancer.org\/#\/schema\/person\/77f1ad8cb112be1b1ac2c792401b18b4\"},\"headline\":\"When a Common Skin Cancer Advances\",\"datePublished\":\"2021-04-28T13:21:28+00:00\",\"dateModified\":\"2021-06-07T19:49:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\"},\"wordCount\":2435,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\/\/www.skincancer.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg\",\"keywords\":[\"advanced basal cell carcinoma\",\"Basal Cell Carcinoma\",\"bcc\",\"mohs surgery\",\"non melanoma skin cancers\"],\"articleSection\":[\"Skin Cancer Information\",\"The Skin Cancer Foundation Journal\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\",\"url\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\",\"name\":\"When a Common Skin Cancer Advances - The Skin Cancer Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.skincancer.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg\",\"datePublished\":\"2021-04-28T13:21:28+00:00\",\"dateModified\":\"2021-06-07T19:49:06+00:00\",\"description\":\"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage\",\"url\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg\",\"contentUrl\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg\",\"width\":900,\"height\":600,\"caption\":\"doctor explaining to patient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.skincancer.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"When a Common Skin Cancer Advances\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.skincancer.org\/#website\",\"url\":\"https:\/\/www.skincancer.org\/\",\"name\":\"The Skin Cancer Foundation\",\"description\":\"Education, prevention, early detection, and treatment of skin cancer\",\"publisher\":{\"@id\":\"https:\/\/www.skincancer.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.skincancer.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.skincancer.org\/#organization\",\"name\":\"The Skin Cancer Foundation\",\"url\":\"https:\/\/www.skincancer.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.skincancer.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/SCF-LOGO.png\",\"contentUrl\":\"https:\/\/www.skincancer.org\/wp-content\/uploads\/SCF-LOGO.png\",\"width\":273,\"height\":291,\"caption\":\"The Skin Cancer Foundation\"},\"image\":{\"@id\":\"https:\/\/www.skincancer.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/skincancerfoundation\",\"https:\/\/x.com\/skincancerorg\",\"https:\/\/www.instagram.com\/skincancerorg\/\",\"https:\/\/www.linkedin.com\/company\/the-skin-cancer-foundation\/\",\"https:\/\/www.pinterest.com\/skincancer\/\",\"https:\/\/www.youtube.com\/user\/SkinCancerFoundation\",\"https:\/\/en.wikipedia.org\/wiki\/Skin_Cancer_Foundation\",\"https:\/\/www.tiktok.com\/@skincancerorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.skincancer.org\/#\/schema\/person\/77f1ad8cb112be1b1ac2c792401b18b4\",\"name\":\"Skin Cancer Foundation\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.skincancer.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e3be62f6deff80433fbdf2527a9e50a4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e3be62f6deff80433fbdf2527a9e50a4?s=96&d=mm&r=g\",\"caption\":\"Skin Cancer Foundation\"},\"url\":\"https:\/\/www.skincancer.org\/blog\/author\/scf-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"When a Common Skin Cancer Advances - The Skin Cancer Foundation","description":"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/","og_locale":"en_US","og_type":"article","og_title":"When a Common Skin Cancer Advances","og_description":"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.","og_url":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/","og_site_name":"The Skin Cancer Foundation","article_publisher":"https:\/\/www.facebook.com\/skincancerfoundation","article_published_time":"2021-04-28T13:21:28+00:00","article_modified_time":"2021-06-07T19:49:06+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg","type":"image\/jpeg"}],"author":"Skin Cancer Foundation","twitter_card":"summary_large_image","twitter_creator":"@skincancerorg","twitter_site":"@skincancerorg","twitter_misc":{"Written by":"Skin Cancer Foundation","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#article","isPartOf":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/"},"author":{"name":"Skin Cancer Foundation","@id":"https:\/\/www.skincancer.org\/#\/schema\/person\/77f1ad8cb112be1b1ac2c792401b18b4"},"headline":"When a Common Skin Cancer Advances","datePublished":"2021-04-28T13:21:28+00:00","dateModified":"2021-06-07T19:49:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/"},"wordCount":2435,"commentCount":2,"publisher":{"@id":"https:\/\/www.skincancer.org\/#organization"},"image":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage"},"thumbnailUrl":"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg","keywords":["advanced basal cell carcinoma","Basal Cell Carcinoma","bcc","mohs surgery","non melanoma skin cancers"],"articleSection":["Skin Cancer Information","The Skin Cancer Foundation Journal"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/","url":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/","name":"When a Common Skin Cancer Advances - The Skin Cancer Foundation","isPartOf":{"@id":"https:\/\/www.skincancer.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage"},"image":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage"},"thumbnailUrl":"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg","datePublished":"2021-04-28T13:21:28+00:00","dateModified":"2021-06-07T19:49:06+00:00","description":"Basal cell carcinoma (BCC) can become advanced and, in rare cases, even life-threatening, but today there are new treatment options for these patients.","breadcrumb":{"@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#primaryimage","url":"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg","contentUrl":"https:\/\/www.skincancer.org\/wp-content\/uploads\/doctor-patient-GettyImages-1296011351.jpg","width":900,"height":600,"caption":"doctor explaining to patient"},{"@type":"BreadcrumbList","@id":"https:\/\/www.skincancer.org\/blog\/when-a-common-skin-cancer-advances\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.skincancer.org\/"},{"@type":"ListItem","position":2,"name":"When a Common Skin Cancer Advances"}]},{"@type":"WebSite","@id":"https:\/\/www.skincancer.org\/#website","url":"https:\/\/www.skincancer.org\/","name":"The Skin Cancer Foundation","description":"Education, prevention, early detection, and treatment of skin cancer","publisher":{"@id":"https:\/\/www.skincancer.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.skincancer.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.skincancer.org\/#organization","name":"The Skin Cancer Foundation","url":"https:\/\/www.skincancer.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.skincancer.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.skincancer.org\/wp-content\/uploads\/SCF-LOGO.png","contentUrl":"https:\/\/www.skincancer.org\/wp-content\/uploads\/SCF-LOGO.png","width":273,"height":291,"caption":"The Skin Cancer Foundation"},"image":{"@id":"https:\/\/www.skincancer.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/skincancerfoundation","https:\/\/x.com\/skincancerorg","https:\/\/www.instagram.com\/skincancerorg\/","https:\/\/www.linkedin.com\/company\/the-skin-cancer-foundation\/","https:\/\/www.pinterest.com\/skincancer\/","https:\/\/www.youtube.com\/user\/SkinCancerFoundation","https:\/\/en.wikipedia.org\/wiki\/Skin_Cancer_Foundation","https:\/\/www.tiktok.com\/@skincancerorg"]},{"@type":"Person","@id":"https:\/\/www.skincancer.org\/#\/schema\/person\/77f1ad8cb112be1b1ac2c792401b18b4","name":"Skin Cancer Foundation","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.skincancer.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e3be62f6deff80433fbdf2527a9e50a4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3be62f6deff80433fbdf2527a9e50a4?s=96&d=mm&r=g","caption":"Skin Cancer Foundation"},"url":"https:\/\/www.skincancer.org\/blog\/author\/scf-admin\/"}]}},"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/posts\/5532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/comments?post=5532"}],"version-history":[{"count":0,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/posts\/5532\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/media\/5535"}],"wp:attachment":[{"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/media?parent=5532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/categories?post=5532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.skincancer.org\/wp-json\/wp\/v2\/tags?post=5532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}